30ID

iShares iBonds Dec 2030Term$CorpETF$Dist

ETFs & Funds · USD · EPA

30IDETFT212

Price

$5.22

+0.33%

Cap

Earnings

30d Trend

+0.1%

30ID
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

4% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level15
Momentum54
Technical45
Fund Quality74
Cost Efficiency80

Raw weighted: 68×Macro 0.99 (1%)=67

RISK

15/100
90d Volatility
3.6%Low
ATR %
0.2%Low daily moves
Max Drawdown (1Y)
-2.1%Resilient

MOMENTUM

54/100
12-1M Momentum
+4.2%Uptrend
6-1M Momentum
-0.6%Flat
1M Return
-0.1%Stable

TECHNICAL

45/100
RSI (14)
51.4Neutral
Price vs SMA200
+0.6%Flat
MACD
0.00Bearish momentum
Bollinger Band
56%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.031Noisy/choppy

FUND QUALITY

74/100
Replication
PhysicalHolds actual assets
Holdings
1,058 positionsHighly diversified
Domicile
Ireland (tax-efficient)15% US withholding tax
Yield
0.05% (Distributing)Growth-focused

COST EFFICIENCY

80/100
Expense Ratio
0.00%Ultra-low cost
Fund Size (AUM)
$124MSmall
Tracking Difference
-0.00%Excellent tracking

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months34
3-12 months55
1-5+ years72

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate iShares iBonds Dec 2030Term$CorpETF$Dist at 67/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 85/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-0.1%

3 MONTHS

-1.1%

12 MONTHS

+4.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. low-risk profile and Cost Efficiency (80) are the primary strengths. Historical volatility is low at 4%. I classify this as a defensive holding — low volatility and high business quality provide portfolio ballast.

defensiveScore: 67/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.